In a landmark court case, an Australian law firm has launched a class action suit against the manufacturer of Nurofen, reports 9News.
The brand’s “Specific Pain” range has all been found to have the same ingredients in all four of the products.
In December 2015, The Federal Court ruled manufactor, Reckitt Benckiser, had engaged in misleading conduct by asserting that its Specific Pain products were formulated to target specific types of pain.
Nurofen Back Pain, Nurofen Period Pain, Nurofen Migraine Pain and Nurofen Tension Headache all contain the same active ingredient: ibuprofen lysine 324mg.
While some may just see it as harmless marketing, the issue arises when patients take multiple pills for multiple ailments.
“Patients may double dose and they may have back pain and a headache, and they may not realise the medication they are taking is the same dose,” Doctor Vivienne Miller said after encountering patients who had made that mistake.
Lawyer Charles Bannister of Bannister Law is now leading the charge in the class action suit.
“It’s a staple item in the Australian household. We are looking at millions of Australians who have purchased these items since 2011,” Mr Bannister said.
“They exploited consumers and they were misleading.”
More information about eligibility and registration information can be found on the Nurofen Class Action website.
You may also like this video – Prince George is growing up so fast!
